A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes

References

1. 1.↵
   2. Steele JC,
   3. Richardson JC,
   4. Olszewski J

   . Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333–59 doi:10.1001/archneur.1964.00460160003001 pmid:14107684

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Hauw JJ,
   3. Daniel SE,
   4. Dickson D, et al

   . Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015–19 doi:10.1212/WNL.44.11.2015 pmid:7969952

   Abstract/FREE Full Text
3. 3.↵
   2. Tsuboi Y,
   3. Slowinski J,
   4. Josephs KA, et al

   . Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003;60:1766–69 doi:10.1212/01.WNL.0000068011.21396.F4 pmid:12796528

   Abstract/FREE Full Text
4. 4.↵
   2. Josephs KA,
   3. Whitwell JL,
   4. Dickson DW, et al

   . Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008;29:280–89 doi:10.1016/j.neurobiolaging.2006.09.019 pmid:17097770

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Price S,
   3. Paviour D,
   4. Scahill R, et al

   . Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 2004;23:663–69 doi:10.1016/j.neuroimage.2004.06.013 pmid:15488416

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Erbetta A,
   3. Mandelli ML,
   4. Savoiardo M, et al

   . Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 2009;30:1482–87 doi:10.3174/ajnr.A1615 pmid:19589886

   Abstract/FREE Full Text
7. 7.↵
   2. Nilsson C,
   3. Markenroth Bloch K,
   4. Brockstedt S, et al

   . Tracking the neurodegeneration of parkinsonian disorders: a pilot study. Neuroradiology 2007;49:111–19 doi:10.1007/s00234-006-0165-1 pmid:17200869

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Seppi K,
   3. Poewe W

   . Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimage Clin N Am 2010;20:29–55 doi:10.1016/j.nic.2009.08.016 pmid:19959017

   CrossRefPubMed
9. 9.↵
   2. Canu E,
   3. Agosta F,
   4. Baglio F, et al

   . Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy. Mov Disord 2011;26:1752–55 doi:10.1002/mds.23739 pmid:21500281

   CrossRefPubMed
10. 10.↵
    2. Knake S,
    3. Belke M,
    4. Menzler K, et al

    . In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 2010;25:1232–38 doi:10.1002/mds.23054 pmid:20222139

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Padovani A,
    3. Borroni B,
    4. Brambati SM, et al

    . Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2006;77:457–63 doi:10.1136/jnnp.2005.075713 pmid:16306152

    Abstract/FREE Full Text
12. 12.↵
    2. Wang J,
    3. Wai Y,
    4. Lin WY, et al

    . Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J Magn Reson Imaging 2010;32:69–75 doi:10.1002/jmri.22229 pmid:20578012

    CrossRefPubMed
13. 13.↵
    2. Whitwell JL,
    3. Master AV,
    4. Avula R, et al

    . Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol 2011;68:753–60 doi:10.1001/archneurol.2011.107 pmid:21670399

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Longoni G,
    3. Agosta F,
    4. Kostić VS, et al

    . MRI measurements of brainstem structures in patients with Richardson's syndrome. Progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord 2011;26:247–55 doi:10.1002/mds.23293 pmid:21412831

    CrossRefPubMed
15. 15.↵
    2. Agosta F,
    3. Pievani M,
    4. Svetel M, et al

    . Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism. Neurobiol Aging 2012;33:2817–26 doi:10.1016/j.neurobiolaging.2012.02.002 pmid:22418735

    CrossRefPubMed
16. 16.↵
    2. Jankovic J,
    3. Rajput AH,
    4. McDermott MP, et al

    . The evolution of diagnosis in early Parkinson disease: Parkinson Study Group. Arch Neurol 2000;57:369–72 doi:10.1001/archneur.57.3.369 pmid:10714663

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Litvan I,
    3. Agid Y,
    4. Calne D, et al

    . Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1–9 doi:10.1212/WNL.47.1.1 pmid:8710059

    Abstract/FREE Full Text
18. 18.↵
    2. Calne DB,
    3. Snow BJ,
    4. Lee C

    . Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(suppl):S125–27 doi:10.1002/ana.410320721 pmid:1510370

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Fahn S,
    2. Marsden CD,
    3. Calne DB,
    4. Goldstein M

    2. Fahn S,
    3. Elton R

    , members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987:153–64
20. 20.↵
    2. Hoehn MM,
    3. Yahr MD

    . Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42 doi:10.1212/WNL.17.5.427 pmid:6067254

    FREE Full Text
21. 21.↵
    2. Folstein MF,
    3. Folstein SE,
    4. McHugh PR

    . ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189–98 doi:10.1016/0022-3956(75)90026-6 pmid:1202204

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Jenkinson M,
    3. Beckmann CF,
    4. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Smith SM,
    3. De Stefano N,
    4. Jenkinson M, et al

    . Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001;25:466–75 doi:10.1097/00004728-200105000-00022 pmid:11351200

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Smith SM,
    3. Zhang Y,
    4. Jenkinson M, et al

    . Accurate, robust and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89 doi:10.1006/nimg.2002.1040 pmid:12482100

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Smith SM

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55 doi:10.1002/hbm.10062 pmid:12391568

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Cherubini A,
    3. Péran P,
    4. Caltagirone C, et al

    . Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage 2009;48:29–36 doi:10.1016/j.neuroimage.2009.06.035 pmid:19540925

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Thiebaut de Schotten M,
    3. Ffytche DH,
    4. Bizzi , et al

    . Atlasing location, asymmetry and inter-subject variability of white matter tracts in the human brain with MR diffusion tractography. Neuroimage 2011;54 1:49–59 doi:10.1016/j.neuroimage.2010.07.055 pmid:20682348

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Ohtsuka K,
    3. Igarashi Y,
    4. Chiba S

    . Cerebellar peduncle lesion without saccadic abnormalities. Ophthalmologica 1992;204:44–48 doi:10.1159/000310265 pmid:1579338

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Nicoletti G,
    3. Tonon C,
    4. Lodi R, et al

    . Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord 2008;23:2370–6 doi:10.1002/mds.22279 pmid:18816803

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Nicoletti G,
    3. Rizzo G,
    4. Barbagallo G, et al

    . Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology 2013;267:843–50. doi:10.1148/radiol.12120364 pmid:23329659

    CrossRefPubMed
31. 31.↵
    2. Quattrone A,
    3. Nicoletti G,
    4. Messina D, et al

    . MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246:214–21 doi:10.1148/radiol.2453061703 pmid:17991785

    CrossRefPubMed
32. 32.↵
    2. William DR,
    3. de Silva R,
    4. Paviour DC, et al

    . Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128:1247–58 doi:10.1093/brain/awh488 pmid:15788542

    Abstract/FREE Full Text
33. 33.↵
    2. Agosta F,
    3. Kostic VS,
    4. Galantucci S, et al

    . The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 2010;32:640–47 doi:10.1111/j.1460-9568.2010.07304.x pmid:20597976

    CrossRefPubMed
34. 34.↵
    2. Worker A,
    3. Blain C,
    4. Jarosz J, et al

    . Diffusion tensor imaging of Parkinson disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. Plos One 2014;9:e112638 doi:10.1371/journal.pone.0112638 pmid:25405990

    CrossRefPubMed
35. 35.↵
    2. Meijer FJ,
    3. van Rumund A,
    4. Tuladhar A, et al

    . Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism. Neuroradiology 2015;57:655–69 doi:10.1007/s00234-015-1515-7 pmid:25845807

    CrossRefPubMed
36. 36.↵
    2. Douaud G,
    3. Behrens TE,
    4. Poupon C, et al

    . In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 2009;46:958–66 pmid:19332141

    CrossRefPubMedWeb of Science